76 related articles for article (PubMed ID: 1322226)
1. Alpha 2-adrenoceptor density in forebrain areas of Zucker rats: no effect of genetic obesity or antiglucocorticoid treatment.
Pesonen U; Miettinen T; Scheinin M; Koulu M
Brain Res; 1992 Mar; 574(1-2):353-6. PubMed ID: 1322226
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats.
Langley SC; York DA
Am J Physiol; 1990 Sep; 259(3 Pt 2):R539-44. PubMed ID: 2204281
[TBL] [Abstract][Full Text] [Related]
3. Differential hypothalamic arginine vasopressin response to glucocorticoid receptor antagonism in lean and obese Zucker rats.
Pesonen U; Jolkkonen J; Huupponen R; Koulu M
Neuroendocrinology; 1992 Aug; 56(2):271-7. PubMed ID: 1407382
[TBL] [Abstract][Full Text] [Related]
4. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats.
Havel PJ; Busch BL; Curry DL; Johnson PR; Dallman MF; Stern JS
Am J Physiol; 1996 Sep; 271(3 Pt 2):R710-7. PubMed ID: 8853395
[TBL] [Abstract][Full Text] [Related]
5. No effect of genetic obesity and mazindol on imidazoline I2 binding sites in the brain of Zucker rats.
Miralles A; Ribas C; Olmos G; García-Sevilla JA
Eur J Pharmacol; 1993 Oct; 243(3):305-8. PubMed ID: 8276084
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1- and beta-adrenergic receptors in brown adipose tissue of lean (Fa/?) and obese (fa/fa) Zucker rats. Effects of cold-acclimation, sucrose feeding and adrenalectomy.
Raasmaja A; York DA
Biochem J; 1988 Feb; 249(3):831-8. PubMed ID: 2895637
[TBL] [Abstract][Full Text] [Related]
7. Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat.
Clapham JC; Turner NC
J Pharmacol Exp Ther; 1997 Sep; 282(3):1503-8. PubMed ID: 9316865
[TBL] [Abstract][Full Text] [Related]
8. Deficits in progesterone-facilitated sexual behaviors and forebrain estrogen and progestin receptors in obese female Zucker rats.
Olster DH; Auerbach ID
Neuroendocrinology; 2000 Dec; 72(6):350-9. PubMed ID: 11146418
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats.
Koulu M; Huupponen R; Hänninen H; Pesonen U; Rouru J; Seppälä T
Neuroendocrinology; 1990 Nov; 52(5):503-10. PubMed ID: 1980723
[TBL] [Abstract][Full Text] [Related]
10. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats.
Wright BE; Porter JR; Browne ES; Svec F
Int J Obes Relat Metab Disord; 1992 Aug; 16(8):579-83. PubMed ID: 1356103
[TBL] [Abstract][Full Text] [Related]
11. Modification of the β-Adrenoceptor Stimulation Pathway in Zucker Obese and Obese Diabetic Rat Myocardium.
Jiang C; Carillion A; Na N; De Jong A; Feldman S; Lacorte JM; Bonnefont-Rousselot D; Riou B; Amour J
Crit Care Med; 2015 Jul; 43(7):e241-9. PubMed ID: 26079096
[TBL] [Abstract][Full Text] [Related]
12. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
Baron BM; Siegel BW
Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alpha 2-adrenoceptor binding sites in rabbit ciliary body membranes.
Jin Y; Verstappen A; Yorio T
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2500-8. PubMed ID: 8163339
[TBL] [Abstract][Full Text] [Related]
14. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK.
Praissman M; Izzo RS
Endocrinology; 1986 Aug; 119(2):546-53. PubMed ID: 3015550
[TBL] [Abstract][Full Text] [Related]
15. Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue.
Hardwick AJ; Linton EA; Rothwell NJ
Endocrinology; 1989 Apr; 124(4):1684-8. PubMed ID: 2784381
[TBL] [Abstract][Full Text] [Related]
16. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
17. Impaired beta-adrenergic signaling pathway in white adipocytes of suckling fa/fa Zucker rats: a defect in receptor coupling.
Mory G; Wiel M; Adli H; Diot-Dupuy F; Ferré P; Bazin R
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1592-8. PubMed ID: 11753576
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine-containing proteins in the CNS of obese Zucker rats are decreased in the absence of changes in the insulin receptor.
Livingston JN; Unger JW; Moxley RT; Moss A
Neuroendocrinology; 1993 Mar; 57(3):481-8. PubMed ID: 7686643
[TBL] [Abstract][Full Text] [Related]
19. Increased growth hormone binding to liver membranes of obese Zucker rats.
Postel-Vinay MC; Durand D; López S; Kayser C; Lavau M
Horm Metab Res; 1990 Jan; 22(1):7-11. PubMed ID: 2407628
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiprogestogen (RU-486) treatment on myometrial and cervical alpha and beta-adrenoceptors in pregnant rabbits.
Falkay G
Hum Reprod; 1990 Nov; 5(8):924-7. PubMed ID: 1964464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
